Sign in
Back
Restoring tacrolimus-induced impaired barrier function
Journal article   Open access  Peer reviewed

Restoring tacrolimus-induced impaired barrier function

Cheryl Aber and Robert S Kirsner
Journal of investigative dermatology, Vol.131(3), pp.554-554
2011-03
DOI: https://doi.org/10.1038/jid.2010.431
PMID: 21307949

Abstract

Imiquimod Humans Immunosuppressive Agents - therapeutic use Receptors, Interleukin-1 - genetics Cell Membrane - physiology Epidermis - physiopathology Models, Animal beta-Defensins - metabolism Aminoquinolines - pharmacology Cell Membrane - drug effects Antimicrobial Cationic Peptides Epidermis - drug effects Mice, Transgenic Tacrolimus - adverse effects Tacrolimus - therapeutic use Animals Dermatitis, Atopic - drug therapy Cell Membrane Permeability - physiology Signal Transduction - drug effects Cathelicidins - metabolism Cell Membrane Permeability - drug effects Lipid Metabolism - drug effects Epidermal Cells Immunosuppressive Agents - adverse effects Signal Transduction - physiology Mice Interleukin-1alpha - pharmacology
url
https://doi.org/10.1038/jid.2010.431View
Published (Version of record) Open

Metrics

6 Record Views
1 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.65 Allergy
1.65.1091 Atopic Dermatitis
Web Of Science research areas
Dermatology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details